Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Altus begins phase I trial of ALTU-237 for hyperoxalurias and kidney stone prevention

Aug. 21, 2007

Esprit Pharma acquires Sanctura XR marketing rights

Aug. 16, 2007

Positive preclinical results from Quark's RNAi compound in acute renal failure

Aug. 9, 2007

Lilly receives approval in Japan for Cialis for erectile dysfunction

Aug. 8, 2007

FDA approves Indevus's Sanctura XR for once-daily treatment of OAB

Aug. 7, 2007

Recent patent claims series of compounds for the treatment of urinary incontincence

Aug. 2, 2007

Recent Astellas patent discloses novel treatment option for urological disorders

July 20, 2007

Plethora secures funds for development of Invicorp for treatment of ED

July 18, 2007

Topline findings from North American Zuidex study

July 16, 2007

Biogen Idec and Cardiokine to codevelop lixivaptan for hyponatremia

July 6, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...